Leah Braukman

Arnall Golden Gregory LLP

+ Follow Contact

Latest Posts › Food and Drug Administration (FDA)

Share:

I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Fee Waivers for Small Businesses: Who Qualifies for the... [Audio]

In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and Genevieve M. Razick, an attorney in our Healthcare and Food & Drug practices, along with Leah D. Braukman, an attorney in our Corporate & Finance practice,...more

7/2/2021 / Biologics , Food and Drug Administration (FDA) , Prescription Drugs , Small Business , User Fees , Waivers

AGG Food & Drug Newsletter - October 2017

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community, including regular updates on legislative initiatives from AGG’s Washington, DC...more

10/20/2017 / Biopharmaceutical , Dietary Supplements , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Manufacturers , Medical Foods , Opioid , Pharmaceutical Industry , Warning Letters

Conditional Optimism or Securities Fraud? Appellate Court Affirms Dismissal of Class Action against Biopharmaceutical Company;...

On August 22, 2017, the United States Court of Appeals for the First Circuit (the “Court”) affirmed the dismissal of a securities fraud class action against Sarepta Therapeutics, Inc. (the “Company”), a biopharmaceutical...more

10/18/2017 / Biopharmaceutical , Food and Drug Administration (FDA) , Securities Act of 1933 , Securities Exchange Act , Securities Fraud

3 Results

View per page

Page: of 1